文献速递心律失常心力衰竭与心肌病瓣膜病与结构性心脏病

致心律失常性心肌病中的炎症与免疫反应:最新综述

Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review.
PubMed 文献 · Circulation · 2021-11-15

本文综述了炎症与免疫反应在致心律失常性心肌病(ACM)发病机制中的证据,包括超过三分之二的ACM心脏存在炎症浸润、部分散发病例检出心脏病毒、患者常符合活动性心肌炎组织学标准及多种自身抗体阳性。尽管炎症/免疫反应的作用尚未完全明确,但其作为表型驱动因素和机制性治疗靶点值得进一步研究。

要点

  • ACM心脏中炎症浸润常见,超过三分之二的心脏标本可见。
  • ACM患者常符合活动性心肌炎组织学标准,并存在多种自身抗体。
  • 炎症作为表型驱动因素和潜在治疗靶点,需进一步转化与临床研究。

核心结论

  • 炎症与免疫反应可能是ACM心肌损伤和表型变异的加重因素,并作为机制性治疗的潜在靶点。

研究设计与样本

  • 本文为叙述性综述,汇总了关于炎症与免疫反应在ACM发病中作用的现有证据并提出转化与临床研究方向。

主要发现

  • 超过三分之二的ACM心脏存在炎症浸润。
  • 部分散发性ACM病例中检测到不同心脏病毒。
  • ACM患者常符合活动性心肌炎的组织学标准。
  • 致心律失常性右心室心肌病患者中抗桥粒胶蛋白-2、抗心脏和抗闰盘自身抗体丰富。

临床怎么用

  • 临床应关注ACM患者中炎症和免疫反应的评估,但其在诊疗中的确切作用尚待进一步研究。

局限性

  • 炎症/免疫反应在ACM中的作用尚未完全明确,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Arrhythmogenic cardiomyopathy (ACM) is a primary disease of the myocardium, predominantly caused by genetic defects in proteins of the cardiac intercalated disc, particularly, desmosomes. Transmission is mostly autosomal dominant with incomplete penetrance. ACM also has wide phenotype variability, ranging from premature ventricular contractions to sudden cardiac death and heart failure. Among other drivers and modulators of phenotype, inflammation in response to viral infection and immune triggers have been postulated to be an aggravator of cardiac myocyte damage and necrosis. This theory is supported by multiple pieces of evidence, including the presence of inflammatory infiltrates in more than two-thirds of ACM hearts, detection of different cardiotropic viruses in sporadic cases of ACM, the fact that patients with ACM often fulfill the histological criteria of active myocarditis, and the abundance of anti-desmoglein-2, antiheart, and anti-intercalated disk autoantibodies in patients with arrhythmogenic right ventricular cardiomyopathy. In keeping with the frequent familial occurrence of ACM, it has been proposed that, in addition to genetic predisposition to progressive myocardial damage, a heritable susceptibility to viral infections and immune reactions may explain familial clustering of ACM. Moreover, considerable in vitro and in vivo evidence implicates activated inflammatory signaling in ACM. Although the role of inflammation/immune response in ACM is not entirely clear, inflammation as a driver of phenotype and a potential target for mechanism-based therapy warrants further research. This review discusses the present evidence supporting the role of inflammatory and immune responses in ACM pathogenesis and proposes opportunities for translational and clinical investigation.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Asatryan B, Asimaki A, Landstrom AP, et al. Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review. Circulation. 2021. PMID: 34780255. doi:10.1161/CIRCULATIONAHA.121.055890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。